Elite Pharmaceuticals Inc (ELTP)

[rrr2003]

The PR you reference is dated September 9/2014 and the more recent info I posted in the link is dated November 19/2014. Nasrat has repeatedly stated ELTP was in constant contact with the FDA in regard to ELI200 (SequestOx). Do you think in that period of time the FDA advised Nasrat of the possible efficacy trial that may be required? Hence the reference to the trial during the CC on November 19.

all you have to do is look at 2014 when he promised NDA submission by the end of the year

Nasrat was on track to file in 2014 until the FDA came along and said - hold on; we need to think about the possibly of requesting an efficacy trial. We'll get back to you on that in due course. Hence the reference to the possible trial in the latest info quoted in the November CC.

http://ir.elitepharma.com/profiles/investor/ResLibraryView.asp?ResLibraryID=74674&GoTopage=1&Category=2163&BzID=2258&t=1956&G=939